In my first post on this blog, I set myself 3 PhD-related goals for 2017. One of those goals was to read more widely, and more frequently, and I decided that doing the #365papers challenge would be a good way to do that.
This reading a paper a day is so difficult when there are a million and one things going on and a thesis to write! I think it’s safe to say that I won’t be doing the #365papers challenge in 2018, but I’m determined to complete this year’s challenge. I’ve enjoyed this month’s reading, but I’ve been doing it in little bursts – meaning I’ve only just finished November’s reading list as this blog post goes live at the beginning of December.. Next month’s reading has to be finished on time because there’s no way I’m panic reading piles of papers on new year’s eve – I’m committed to finishing this thing on a high!
November’s reading:
- Research Involvement and Engagement: reflections so far and future directions
- The impact of involvement on researchers: a learning experience
- Power to the people: To what extent has public involvement in applied health research achieved this?
- Factors associated with reporting results for pulmonary clinical trials in ClinicalTrials.gov
- A systematic review and development of a classification framework for factors associated with missing patient-reported outcome data
- The treatment in morning versus evening (TIME) study: analysis of recruitment, follow-up and retention rates post recruitment
- Can routine data be used to support cancer clinical trials? A historical baseline on which to build: retrospective linkage of data from the TACT breast cancer trial and the National Cancer Data Repository
- Network methods to support user involvement in qualitative data analyses: an introduction to Participatory Theme Elicitation
- A systematic literature review of evidence-based clinical practice for rare diseases: what are the perceived and real barriers for improving the evidence and how can they be overcome?
- Improving readiness for recruitment through simulated trial activation: the Adjuvant Steroids in Adults with Pandemic influenza (ASAP) trial
- The marketing plan and outcome indicators for recruiting and retaining parents in the HomeStyles randomised controlled trial
- Advancing ‘real-world’ trials that take account of social context and human volition
- Impact of a deferred recruitment model in a randomised controlled trial in primary care (CREAM) study
- Framing the conversation: use of PRECIS-2 ratings to advance understanding of pragmatic trial design domains
- Lessons from the field: the conduct of randomised controlled trials in Botswana
- Participant recruitment and retention in longitudinal preconception randomised trials: lessons learnt from the Calcium and Pre-eclampsia (CAP) trial
- A framework for the design, conduct and interpretation of randomised controlled trials in the presence of treatment changes
- Peak Gender Gap: Women at the top of science agencies
- Survey of risks and benefits communication strategies by research nurses
- The fractured logic of blinded peer review in journals
- Choosing wisely: How to fulfil the promise in the next 5 years
- Catch-22, clinical trial edition: Protecting women and children
- Insufficient recruitment and premature discontinuation of clinical trials in Switzerland: qualitative study with trialists and other stakeholders
- Rebranding retractions and the honest error hypothesis
- Participation and retention can be high in randomised controlled trials targeting underserved populations: A systematic review and meta-analysis
- Rheumatoid arthritis patients treated in trial and real world settings: comparison of randomised trials with registries
- Prevalence, characteristics, and publication of discontinued randomised trials
- Clear obstacles and hidden challenges: understanding recruiter perspectives in six pragmatic randomised controlled trials
- The intellectual challenges and emotional consequences of equipoise contributed to the fragility of recruitment in six randomised controlled trials
- Patient enrollment and logistical problems top the list of difficulties in clinical research: a cross-sectional survey